Northwire Canada EditionTuesday, July 14, 2026
Sign inSubscribe
Northwire
⌕
WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8% WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8%
Financings

Burcon insiders increase commitment to placement

By The Northwire Desk — AI Analysis Dec 01, 2025 · 19:24 BU · 1.76 Burcon NutraScience Corp
BU · Price

Executive Summary

  • Burcon NutraScience Corp. insiders have increased their commitment to its previously announced non-brokered private placement of convertible debentures, raising the total insider participation above the initial minimum of $2.0 million.
  • The increased insider interest has necessitated a delay in the closing of the offering, which was originally expected to close on or about November 28, 2025.
  • The company anticipates that the increased participation will require disinterested shareholder approval, and the final terms and conditions of the offering may change from what was previously announced.

Key Details

  • Insider Participation Increase: Insiders have increased their commitment to the non-brokered private placement of convertible debentures beyond the previously announced minimum of $2.0 million in principal amount.
  • Closing Delay: The closing of the offering, originally expected on or about November 28, 2025, has been extended due to the timing required to obtain shareholder approval for the increased insider participation.
  • Regulatory Requirements: The offering is subject to execution of subscription agreements and conditions including regulatory approvals, specifically the approval of the Toronto Stock Exchange and disinterested shareholders.
  • Potential Term Changes: The company is working with key investors to finalize terms, which may differ from the initial announcement.
  • Management Commentary: CEO Kip Underwood stated that the increased investment by insiders and largest shareholders demonstrates confidence in the business plan, sales trajectory, and commercial momentum into 2026.

Notable Quotes

  • "Burcon insiders and its largest shareholders have once again shown confidence in our business plan and sales trajectory by expanding their investment. Their continued support underscores the commercial momentum we carry into 2026 and reinforces our ability to execute and deliver value for shareholders." — Kip Underwood, Chief Executive Officer
Read the original news release →

More from Burcon NutraScience Corp

Jun 26, 2026 · 16:21

Stonegate updates coverage on Burcon Nutrascience Corporation (BU) 4Q26

Earnings Jun 24, 2026 · 16:12

494% revenue jump overshadowed by $14.3M loss, negative equity, and costly insider debt; liquidity a red flag.

Earnings Jun 16, 2026 · 08:01

Commercial scaling accelerates, but negative equity and explicit capital calls keep the risk/reward skewed to the downside.

Production / Operations Apr 20, 2026 · 08:01

Burcon NutraScience Ramps Production Amidst Cash Burn Concerns

Production / Operations Feb 27, 2026 · 20:10

Burcon closes $2.75M second tranche of placement

Financings Feb 27, 2026 · 16:38

Burcon Closes Second Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million

Financings